Results 161 to 170 of about 921 (218)

Four‐dimensional immuno‐mechanobiomaterials: Dynamic material cues that program host response to prevent fibrosis and enable regeneration

VIEW, EarlyView.
Dynamic immuno‐mechanobiomaterials with time‐programmed mechanical adaptation orchestrate host responses through precise mechanotransduction and immune‐stromal regulation. These adaptive biomaterials minimize mechanical mismatch, attenuate the forign dy response and fibrosis, promote angiogenesis and controlled extracellular matrix remodeling, and ...
Gobinath Vellapalayam Manoharan, Kathirvel Ayyaswamy, Parthasarathy Vellaichamy, Nagarajan Deivanayagam Pillai, Rithik Gobinath   +4 more
wiley   +1 more source

Upper Atmosphere Dynamics and Drivers of Volatiles Loss from Terrestrial-Type (Exo)Planets. [PDF]

Space Sci Rev
Kubyshkina D, Way MJ, Dandouras I, Lammer H, Lanza AF, Lingam M, Nakamura R, Persson M, Scherf M, Seki K.   +9 more
europepmc   +1 more source

Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology

VIEW, EarlyView.
Plant‐derived nanovesicles (PDNVs) are naturally secreted by fruit, vegetables, seeds, leaves and other natural sources. Used as drug delivery systems, they can combine intrinsic therapeutic activity, enhanced skin permeation and cargo‐carrying capacity, suitable for dermatological and cosmetic applications including hydration, antioxidant/anti ...
Dorotea Fiore, Beatrice Pellegrini, Antonia Mancuso, Maria Chiara Cristiano, Salvatore Panza, Donatella Paolino   +5 more
wiley   +1 more source

The Use of Topical Tacrolimus as Adjunct Therapy to Corticosteroid in a High-Risk Penetrating Keratoplasty: A Systematic Review and Meta-Analysis. [PDF]

J Curr Ophthalmol
Advani MS, Widyawati S.
europepmc   +1 more source

Eosinophilic Sialodochitis Identified in Duct Remnant After Submandibular Gland Resection

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Eosinophilic sialodochitis (ES) is an increasingly recognized cause of recurrent sialadenitis but likely remains underdiagnosed as it is commonly considered to be nonspecific chronic sialadenitis. ES is likely increasing in prevalence in association with the growing number of allergic diseases and should be considered in patients presenting ...
Edward Tannenbaum, Claire Orth, Nicole Becker, Henry Hoffman   +3 more
wiley   +1 more source

Physiological Data Collected From Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares. [PDF]

Gastroenterology
Hirten RP, Danieletto M, Sanchez-Mayor M, Whang JK, Lee KW, Landell K, Zweig M, Helmus D, Fuchs TJ, Fayad ZA, Nadkarni GN, Keefer L, Suarez-Farinas M, Sands BE.   +13 more
europepmc   +1 more source

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Systemic psoriasis treatment options have rapidly expanded in Japan, including the approval of tyrosine kinase 2 and interleukin‐36 receptor inhibitors in 2022. However, contemporary real‐world treatment patterns across plaque, erythrodermic, and generalized pustular psoriasis remain incompletely characterized.
Yayoi Tada, Yoshiko Maeda, Miyuki Hasegawa, Motonobu Sakaguchi, Takamasa Hashimoto, Teruko Narusawa, Nobuyoshi Takabayashi, Tomoko Takahashi, Taisuke Kondo, Shingo Kuroda   +9 more
wiley   +1 more source

Wearable Devices Identify Altered Sleep Characteristics and Sleep Trajectories in Active Inflammatory Bowel Disease. [PDF]

Clin Gastroenterol Hepatol
Hirten RP, Danieletto M, Whang JK, Landell K, Helmus D, Said H, Ensari I, Shah N, Bagiella E, Figueiro MG, Sands BE, Suarez-Farinas M.   +11 more
europepmc   +1 more source

Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety

The Journal of Dermatology, EarlyView.
ABSTRACT Systemic treatments for moderate‐to‐severe plaque psoriasis have been advanced from broad immunosuppressants up to agents more selectively targeting cytokines, cytokine receptors, or intracellular signaling. The current systemic treatments mainly consist of conventional systemic agents, biologics targeting tumor necrosis factor (TNF)‐α ...
Teppei Hagino, Naoko Kanda
wiley   +1 more source

Local cytokine release syndrome with cervical angioedema following CAR-T cell therapy. [PDF]

Haematologica
Lahad K, Beyar-Katz O, Dallasheh M, Shibli N, Ringelstein-Harlev S, Zektzer M, Yehudai-Ofir D, Zuckerman T, Damri NT, Greenbaum U, Cohen L.   +10 more
europepmc   +1 more source